These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Expression of Bruton´s tyrosine kinase in different type of brain lesions of multiple sclerosis patients and during experimental demyelination. Elkjaer ML; Waede MR; Kingo C; Damsbo K; Illes Z Front Immunol; 2023; 14():1264128. PubMed ID: 38022591 [TBL] [Abstract][Full Text] [Related]
5. Cryogel scaffolds for regionally constrained delivery of lysophosphatidylcholine to central nervous system slice cultures: A model of focal demyelination for multiple sclerosis research. Eigel D; Zoupi L; Sekizar S; Welzel PB; Werner C; Williams A; Newland B Acta Biomater; 2019 Oct; 97():216-229. PubMed ID: 31425890 [TBL] [Abstract][Full Text] [Related]
6. S100B Impairs Oligodendrogenesis and Myelin Repair Following Demyelination Through RAGE Engagement. Santos G; Barateiro A; Brites D; Fernandes A Front Cell Neurosci; 2020; 14():279. PubMed ID: 33100970 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms Involved in the Remyelinating Effect of Sildenafil. Díaz-Lucena D; Gutierrez-Mecinas M; Moreno B; Martínez-Sánchez JL; Pifarré P; García A J Neuroimmune Pharmacol; 2018 Mar; 13(1):6-23. PubMed ID: 28776122 [TBL] [Abstract][Full Text] [Related]
8. Distinct patterns of glia repair and remyelination in antibody-mediated demyelination models of multiple sclerosis and neuromyelitis optica. Liu Y; Given KS; Owens GP; Macklin WB; Bennett JL Glia; 2018 Dec; 66(12):2575-2588. PubMed ID: 30240044 [TBL] [Abstract][Full Text] [Related]
9. Monitoring recovery after CNS demyelination, a novel tool to de-risk pro-remyelinating strategies. Henriet E; Martin EM; Jubin P; Langui D; Mannioui A; Stankoff B; Lubetzki C; Khakhalin A; Zalc B Brain; 2023 Jun; 146(6):2453-2463. PubMed ID: 36995973 [TBL] [Abstract][Full Text] [Related]
10. Bruton's tyrosine kinase inhibition suppresses pathological retinal angiogenesis. Chen S; Liu Y; Zhang Y; Guo X; Bai T; He K; Zhu Y; Lei Y; Du M; Wang X; Liu Q; Yan H Br J Pharmacol; 2024 Oct; ():. PubMed ID: 39374939 [TBL] [Abstract][Full Text] [Related]
11. Investigating demyelination, efficient remyelination and remyelination failure in organotypic cerebellar slice cultures: Workflow and practical tips. Gorter RP; Dijksman NS; Baron W; Colognato H Methods Cell Biol; 2022; 168():103-123. PubMed ID: 35366978 [TBL] [Abstract][Full Text] [Related]
12. Bruton's tyrosine kinase as a promising therapeutic target for multiple sclerosis. Saberi D; Geladaris A; Dybowski S; Weber MS Expert Opin Ther Targets; 2023; 27(4-5):347-359. PubMed ID: 37272515 [TBL] [Abstract][Full Text] [Related]
15. Bruton's Tyrosine Kinase Inhibition in the Treatment of Preclinical Models and Multiple Sclerosis. Steinmaurer A; Wimmer I; Berger T; Rommer PS; Sellner J Curr Pharm Des; 2022; 28(6):437-444. PubMed ID: 34218776 [TBL] [Abstract][Full Text] [Related]
16. Csf1 Deficiency Dysregulates Glial Responses to Demyelination and Disturbs CNS White Matter Remyelination. Wylot B; Mieczkowski J; Niedziolka S; Kaminska B; Zawadzka M Cells; 2019 Dec; 9(1):. PubMed ID: 31906095 [TBL] [Abstract][Full Text] [Related]
17. Bruton's tyrosine kinase inhibition reduces disease severity in a model of secondary progressive autoimmune demyelination. Evonuk KS; Wang S; Mattie J; Cracchiolo CJ; Mager R; Ferenčić Ž; Sprague E; Carrier B; Schofield K; Martinez E; Stewart Z; Petrosino T; Johnson GA; Yusuf I; Plaisted W; Naiman Z; Delp T; Carter L; Marušić S Acta Neuropathol Commun; 2023 Jul; 11(1):115. PubMed ID: 37438842 [TBL] [Abstract][Full Text] [Related]
18. Live imaging of remyelination after antibody-mediated demyelination in an ex-vivo model for immune mediated CNS damage. Harrer MD; von Büdingen HC; Stoppini L; Alliod C; Pouly S; Fischer K; Goebels N Exp Neurol; 2009 Apr; 216(2):431-8. PubMed ID: 19320002 [TBL] [Abstract][Full Text] [Related]
19. Modeling demyelination and endogenous remyelination in spinal cord Hawker B; Dhakal M; Connor B; McCaughey-Chapman A Front Cell Neurosci; 2024; 18():1345042. PubMed ID: 38988661 [TBL] [Abstract][Full Text] [Related]
20. Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure. Lombardi M; Parolisi R; Scaroni F; Bonfanti E; Gualerzi A; Gabrielli M; Kerlero de Rosbo N; Uccelli A; Giussani P; Viani P; Garlanda C; Abbracchio MP; Chaabane L; Buffo A; Fumagalli M; Verderio C Acta Neuropathol; 2019 Dec; 138(6):987-1012. PubMed ID: 31363836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]